Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FK759
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,790
Award facts
- Contract value 100% obligated
- $11,789.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count) valued at $11,789.94 under a firm fixed price contract type. The award, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
The contract falls within the Defense Logistics Agency's Medical Supply Chain operations, supporting pharmaceutical procurement for defense healthcare needs. Calquence is a specialty medication used in hematology and oncology treatment protocols, reflecting the breadth of AmerisourceBergen's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to federal healthcare systems. The firm fixed price structure and the small-to-moderate transaction value are consistent with routine delivery orders under AmerisourceBergen's overarching prime vendor agreement, which enables flexible fulfillment of military medical requirements across the globe while maintaining competitive positioning for the upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DR26FK759?
SPE2DR26FK759 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FK759 worth?
The government has obligated $11,790 on SPE2DR26FK759.
Is contract SPE2DR26FK759 an order under another contract?
Yes. SPE2DR26FK759 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK759 competed?
The extent of competition for SPE2DR26FK759 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award